Clinical Trials Logo

Filter by:
NCT ID: NCT04039386 Not yet recruiting - Hip Osteoarthritis Clinical Trials

Psychosocial Interventions for Young Adults With Hip Pain

Start date: August 1, 2024
Phase: N/A
Study type: Interventional

Psychosocial conditions are common in young adults with hip pain including depression, anxiety, pain catastrophizing, and narcotic use. The incidence of these conditions is not well defined. Interventions to optimize psychosocial conditions with non-surgical or surgical treatments has not been investigated. The goal of this project is to determine the incidence of psychosocial conditions in the young adult population with hip pain and determine if cognitive based therapy can improve clinical outcomes in these individuals.

NCT ID: NCT04036045 Not yet recruiting - Childhood Cancer Clinical Trials

Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

Start date: January 2025
Phase:
Study type: Observational

Early microRNAs (miRs) and Cardiac Magnetic Resonance (CMR)-derived strain analysis and detection of genes contributing to Anthracycline-Induced Cardiotoxicity (AIC) sensitivity and resistance will identify pediatric cancer patients most and least likely to develop AIC.

NCT ID: NCT04035629 Not yet recruiting - Clinical trials for Bronchopulmonary Dysplasia

129Xe MRI in Pediatric Population With BPD

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

Hyperpolarized (HP) gas magnetic resonance imaging (MRI) of the lungs offers additional information that cannot be obtained with CT scan, the current gold standard for imaging this disorder. As a nonionizing technique, MRI is an ideal modality for pulmonary imaging; in particular in the infant and pediatric population. Nevertheless, due to the low proton density of the lung parenchyma (only ~20% that of solid tissues), numerous air-tissue interfaces that lead to rapid signal decay, and cardiac and respiratory sources of motion that further degrade image quality , MRI has played a limited role in the evaluation of lung pathologies. In this setting, HP gas (using 129Xe) MRI may play a role in helping determine the regional distribution of alveolar sizes, partial pressure of oxygen, alveolar wall thickness, and gas transport efficiency of the microvasculature within the lungs of infants with a diagnosis of bronchopulmonary dysplasia (BPD).

NCT ID: NCT04025008 Not yet recruiting - Clinical trials for Peripheral Arterial Disease

A Clinical Evaluation of the MicroSTent® PeripherAl Vascular SteNt in Subjects With Arterial Disease Below the Knee

STAND
Start date: October 2019
Phase: N/A
Study type: Interventional

This prospective pivotal study is a double arm, randomized multi-center study evaluating the safety and performance of the MicroStent peripheral vascular stent system for use in arterial lesions below the knee. A total of 177 subjects will be enrolled at up to 25 centers and followed for up to 3 years, with the primary safety and efficacy endpoints evaluated 30 days and 6 months, respectively, post-implant.

NCT ID: NCT04023240 Not yet recruiting - Cancer Clinical Trials

68-Ga-FAPI PET Imaging in Malignancy

Start date: July 2023
Phase: Phase 2
Study type: Interventional

This feasibility trial studies the use of gallium-68 (68Ga)-FAPI as the imaging agent for positron emission tomography (PET)/computed tomography (CT), collectively PET/CT, in patients with various cancers. PET uses a radioactive substance called 68Ga-FAPI, which attaches to cancer activated fibroblasts. The PET scanner takes pictures that capture where the radioactive drug is "lighting up" and attaching to tumor cells, which may help doctors recognize differences between tumor and healthy tissue. CT uses X-rays to make a picture of areas inside the body. Using 68Ga-FAPI in diagnostic procedures, such as PET/CT, may allow doctors to identify smaller tumors than standard imaging.

NCT ID: NCT04020029 Not yet recruiting - Cancer Clinical Trials

Leveraging Mindsets to Improve Health and Wellbeing in Patients With Cancer

Start date: September 2024
Phase: N/A
Study type: Interventional

Primary Objectives: Mindsets have been rigorously studied in the domains of development, education, and more recently, in health and disease. However, there are no large-scale longitudinal studies of the mindsets held by cancer patients and how they may affect treatment outcomes, physical health, and psychological well-being. This randomized, single-blind, treatment-as-usual (TAU) control study aims to assess (1) mindsets at four time points spanning from the point of diagnosis to six weeks post-treatment to patients who are newly diagnosed with cancer and undergoing treatment with curative intent, and (2) the impact of a brief but targeted mindset intervention to help instill more useful mindsets about the nature of cancer and the role of the body on patient reported measures of physical and psychological health. This study aims to add to the existing literature on psychosocial interventions for cancer patients and survivors while addressing the substantial time and cost limitations of traditional interventions. It also contributes to the body of research indicating that mindsets play an important role in both health and wellbeing. Secondary Objectives: This study has two secondary objectives. First, we aim to determine the impact of patient mindsets on measures of treatment (treatment efficacy and treatment related adverse events) and psychosocial health (stress, coping, mood, emotions). Second, we aim to understand the relationship between patient mindsets and biomarkers of immune and inflammatory processes in patients undergoing cancer treatment

NCT ID: NCT04017351 Not yet recruiting - Surgery Clinical Trials

Virtual Assistant for Plastic Surgery Patients

Start date: September 2024
Phase: N/A
Study type: Interventional

Researchers are trying determine the long term impact when patients have access to the artificial intelligence virtual assistant (AIVA) as a complimentary resource.

NCT ID: NCT04016818 Not yet recruiting - Breast Cancer Clinical Trials

Pilot Breast-Dedicated PET Camera With 1 Millimeter Spatial Resolution

Start date: December 2024
Phase: Early Phase 1
Study type: Interventional

This is a research study of a novel, "breast-dedicated" positron emission tomography (PET) camera with 1 millimeter spatial resolution. The main goal of the study is for the personnel to understand practical and logistical issues with using the camera in the clinic

NCT ID: NCT04015791 Not yet recruiting - Lumbar Disc Disease Clinical Trials

NOCISCAN-Lumbar Spine (LS) Clinical Evaluation Study

Start date: April 1, 2023
Phase:
Study type: Observational

A prospective, double blinded, multi-center study to assess the validity and clinical utility of the pre-operative NOCISCAN-LS software in the identification of painful lumbar discs, and the correlation with improved surgical outcomes at 3, 6, 12 and 24 months (follow-up) following spine surgery in a single enrollment arm of subjects with chronic symptomatic single level degenerative disc disease (DDD) at L3 to S1, but with two evaluation groups- Match Group and Miss Group,of subjects based on the association between the NOCISCORE results of treated and untreated disc levels.

NCT ID: NCT04011306 Not yet recruiting - Burn Wound Clinical Trials

A Feasibility Study of a Novel Phototherapy System for the Management of Acute Burns

Start date: February 2020
Phase: N/A
Study type: Interventional

The primary purpose of this feasibility study is to evaluate safety and effectiveness in healing outcomes of patients treated with Lumina24TM BLU (treatment), a Continuous Low-Irradiance Phototherapy (CLIP) device, as compared to standard of care (SOC) therapy (control) for the treatment of acute burns.